CDISC SDTM and ADaM for survival data - ppt download
Progression-free survival as a surrogate for overall survival in oncology trials: a methodological systematic review | British Journal of Cancer
Basics of survival statistics for oncologists Mehta A, Sharma A - J Curr Oncol
Trina Slabiak
Estimating progression-free survival in patients with glioblastoma using routinely collected data | Journal of Neuro-Oncology
The Importance of Disease-Free Survival as a Clinical Trial Endpoint: A Qualitative Study Among Canadian Survivors of Lung Cancer | SpringerLink
Study of NSCLC, melanoma outcomes points to surrogacy between real-world endpoints and clinical trial endpoints - The Cancer Letter
Outcomes and endpoints in trials of cancer treatment: the past, present, and future - The Lancet Oncology
Neoadjuvant trials in early breast cancer: pathological response at surgery and correlation to longer term outcomes – what does it all mean? | BMC Medicine | Full Text
Extrapolation from Progression Free Survival to Overall Survival in Oncology | PPT
Survival analysis in hematologic malignancies: recommendations for clinicians | Haematologica
Are progression-free and disease-free survival the new gold standard for cancer trials? | Cancer World Archive
Survival analysis - Wikipedia
A correlation analysis to assess event-free survival as a trial-level surrogate for overall survival in early breast cancer - eClinicalMedicine
Ovarian cancer clinical trial endpoints: Society of Gynecologic Oncology white paper
Definition of Composite Progression-Free Survival End Point | Download Table
Clinical Trial Endpoints in Cancer Research: Four Terms You Should Know
Overall survival of patients with metastatic breast cancer in Sweden: a nationwide study | British Journal of Cancer
Disease Free Survival - an overview | ScienceDirect Topics
Survival Analysis
Extrapolation from Progression Free Survival to Overall Survival in Oncology | PPT
